v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows From Operating Activities:    
Net loss $ (32,143,764) $ (14,394,757)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 7,482,760 3,897,050
Amortization of in-process research and development 2,293,750
Deferred income tax expense 33,030 528,480
Changes in operating assets and liabilities:    
Accounts receivable, net of allowances (1,079,055)
Inventory (372,897) (7,070,487)
Prepaid expenses (1,721,107)
Accounts payable (4,351,445) 3,964,688
Accrued expenses 19,964,449 8,722,168
Due to related party (1,292,285) 4,352,858
Net Cash (Used In) Provided By Operating Activities (11,186,564)
Cash Flows From Investing Activities    
License payments (5,000,000)
Net Cash Used In Investing Activities (5,000,000)
Cash Flows From Financing Activities    
Deferred financing costs (169,252)
Net proceeds from issuance of common stock 15,063,542
Net Cash Provided by Financing Activities 14,894,290
Net Change in Cash and Cash Equivalents (1,292,274)
Cash and Cash Equivalents – Beginning of Period 3,924,908 112
Cash and Cash Equivalents – End of Period 2,632,634 112
Supplemental Disclosures of Cash Flow Information and Non-cash Transactions:    
Interest Paid $ 14,460